Which of the following medications is an anticoagulant agent?
A. Aspirin B. Warfarin C. Clopidogrel D. Streptokinase
B. Warfarin
Warfarin is a classic oral anticoagulant. It inhibits vitamin K epoxide reductase, which reduces the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) and proteins C and S, thereby impairing the coagulation cascade and preventing thrombus formation.
Aspirin is an antiplatelet agent (irreversibly inhibits COX-1, reducing thromboxane A2 and platelet aggregation).
Clopidogrel is also an antiplatelet agent (P2Y12 ADP-receptor antagonist).
Streptokinase is a thrombolytic (fibrinolytic) agent that activates plasminogen to dissolve existing clots.
These categories are distinct: anticoagulants primarily target the clotting cascade, antiplatelet target platelets, and thrombolytics break down formed fibrin.
Exam tip – Remember the difference:
Drug class | Example |
|---|---|
Anticoagulant | Warfarin, Heparin |
Antiplatelet | Aspirin, Clopidogrel |
Thrombolytic | Streptokinase, Alteplase |
Key takeaway: Warfarin prevents the formation and extension of blood clots; it does not directly dissolve existing clots.
Which of the following conditions is a serious adverse reaction of fluoroquinolone therapy?
A. Eczema
B. Bleeding
C. Depression
D. Q-T interval prolongation
D. Q-T interval prolongation
Fluoroquinolones (e.g., ciprofloxacin, levofloxacin, moxifloxacin) are associated with several serious adverse effects. One well-established cardiovascular risk is concentration-dependent prolongation of the QT interval on ECG. This can lead to torsades de pointes and other serious ventricular arrhythmias (particularly with agents such as moxifloxacin, and in the presence of risk factors such as electrolyte imbalances, other QT-prolonging drugs, bradycardia, or underlying heart disease).
A. Eczema is not a characteristic or highlighted serious adverse reaction of this class (photosensitivity or other rashes can occur, but eczema is not typical).
B. Bleeding is not a primary direct adverse effect (rare aortic events can secondarily involve bleeding risk, but this is not listed as a standard reaction in the options’ sense).
C. Depression can occur as part of CNS/psychiatric effects (which include mood changes, anxiety, and rarer severe reactions), and these are also taken seriously with regulatory warnings. However, QT prolongation is the more classically emphasized, objective, and potentially immediately life-threatening cardiac adverse reaction among the listed choices.
Product labeling and clinical reviews routinely list QT-interval prolongation (with the associated arrhythmia risk) among the important serious adverse reactions requiring caution or avoidance in at-risk patients.
Exam tip: Important fluoroquinolone adverse effects
- QT interval prolongation.
- Tendinitis and tendon rupture.
- Peripheral neuropathy.
- CNS effects (confusion, insomnia, seizures).
- Dysglycemia (hypoglycemia or hyperglycemia).
- Exacerbation of myasthenia gravis.
Key takeaway: Remember the association between fluoroquinolones and QT prolongation, particularly with moxifloxacin and levofloxacin.
Which of the following is the reason doxycycline should be avoided in children less than 12 years?
A High toxicity
B. Low tolerability
C. Risk of bleeding
D. Teeth discoloration
D. Teeth discoloration
Doxycycline (and other tetracyclines) is generally avoided in children under 8–12 years of age (guidelines vary by country and indication) because it can bind to calcium in developing teeth and bones. This leads to permanent yellow-gray-brown discoloration of the teeth and, less commonly, enamel hypoplasia. The risk is highest during periods of active tooth calcification (roughly from the second half of pregnancy through about age 8).
High toxicity, low tolerability, and risk of bleeding are not the primary reasons for age-based avoidance of doxycycline.
Note that short courses of doxycycline are sometimes used even in younger children for serious infections (e.g., Rocky Mountain spotted fever) when the benefits clearly outweigh the low risk of staining, but the classic and most important reason for the general restriction remains dental discoloration.
Important exam note:
The age restriction needs clarification:
- Traditional tetracyclines are generally avoided in children younger than 8 years.
- Short courses of doxycycline are considered acceptable in children of all ages for certain serious infections, particularly rickettsial diseases, because the risk of dental staining is very low.
Exam tip: Associate tetracyclines with permanent tooth discoloration in young children.
Which of the following is the mechanism of action of liraglutide?
A. Dipeptidyl peptidase 4 inhibitor
B. Glucagon like peptide-1receptor agonist
C. Sodium /glucose co-transporter 2 inhibitor
D. Activate peroxisome proliferator-activated receptor
B. Glucagon like peptide-1 receptor agonist
Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the actions of endogenous GLP-1 by binding to and activating GLP-1 receptors, which increases glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety.
A describes DPP-4 inhibitors (e.g., sitagliptin, saxagliptin), which raise endogenous GLP-1 levels by blocking its degradation.
C describes SGLT2 inhibitors (e.g., empagliflozin, dapagliflozin).
D describes PPAR-γ agonists (thiazolidinediones such as pioglitazone).
High-yield exam tip: Know these antidiabetic drug classes
Drug class | Examples |
|---|---|
GLP-1 receptor agonists | Liraglutide, Semaglutide, Dulaglutide |
DPP-4 inhibitors | Sitagliptin, Linagliptin |
SGLT2 inhibitors | Empagliflozin, Dapagliflozin |
Thiazolidinediones (PPAR-γ agonists) | Pioglitazone |
A child weighing 25 kg is prescribed acetazolamide 2.5 mg/kg every 12 hours. Acetazolamide is available in a liquid dosage form with strength of 25 mg/ml.
How many milliliters would the patient be administered per dose?
A 2.5
B. 5.0
C. 7.5
D. 10
A. 2.5
Calculation:
- Prescribed dose = per dose.
- Available strength =
- Volume to administer = per dose.
Disclaimer:
The pharmacy multiple-choice questions (MCQs) and explanations in this post are intended for educational and exam-preparation purposes only. They are designed to help pharmacy students, PharmD candidates, and healthcare professionals prepare for licensing and competitive examinations, including NAPLEX, DHA, MOH, HAAD, SPLE, PEBC, and other Prometric exams.
The content is based on general pharmacological knowledge and commonly accepted clinical principles. Although every effort has been made to ensure accuracy, guidelines, drug information, and clinical recommendations may change over time.
These questions should not be considered a substitute for official clinical guidelines, professional judgment, or individualized medical advice. Always consult reliable references and current prescribing information before making clinical decisions.
PharmaAssist is an independent educational platform and is not affiliated with any official examination board or regulatory authority.


0 Comments